@aliciamconway.bsky.social
Reposted
📢 We’re now accepting poster submissions for our upcoming HPB event!
Whether your work focuses on research, translational studies, clinical insights, or patient experience, we want to hear from you.
📧 Send your posters to gmcancer.academy@nhs.net by 12 January 2026 (COP)
Whether your work focuses on research, translational studies, clinical insights, or patient experience, we want to hear from you.
📧 Send your posters to gmcancer.academy@nhs.net by 12 January 2026 (COP)
November 18, 2025 at 10:00 AM
📢 We’re now accepting poster submissions for our upcoming HPB event!
Whether your work focuses on research, translational studies, clinical insights, or patient experience, we want to hear from you.
📧 Send your posters to gmcancer.academy@nhs.net by 12 January 2026 (COP)
Whether your work focuses on research, translational studies, clinical insights, or patient experience, we want to hear from you.
📧 Send your posters to gmcancer.academy@nhs.net by 12 January 2026 (COP)
Some excellent PhD projects with some amazing research teams!
🚨Applications are open for our MB-PhD scheme!
If you're a University of Manchester, Leeds or St Andrews medical student looking to combine your clinical training with a research PhD, check out our new MB-PhD projects.
📅 9 March 2026
🔗https://crukcentre.manchester.ac.uk/opportunity_category/mb-phd/
If you're a University of Manchester, Leeds or St Andrews medical student looking to combine your clinical training with a research PhD, check out our new MB-PhD projects.
📅 9 March 2026
🔗https://crukcentre.manchester.ac.uk/opportunity_category/mb-phd/
October 20, 2025 at 9:28 PM
Some excellent PhD projects with some amazing research teams!
Reposted
We have put together a comprehensive catalogue of resources to help you learn more about Cancer of Unknown Primary (CUP). We understand that the unknown is scary. Sometimes knowing information is available can help. Visit www.worldcupalliance.org for free access to resources and research.
July 8, 2025 at 7:32 PM
We have put together a comprehensive catalogue of resources to help you learn more about Cancer of Unknown Primary (CUP). We understand that the unknown is scary. Sometimes knowing information is available can help. Visit www.worldcupalliance.org for free access to resources and research.
Reposted
We have a position open for a postdoctoral researcher. This is a unique opportunity to develop #liquidbiopsy methods to non-invasively analyse colorectal cancer plasticity and response to treatments. The position is part of the CRC-STARS consortium. @cruknbc.bsky.social cruknbc.org/vacancy-post...
Vacancy: Postdoctoral Scientist - National Biomarker Centre
We are recruiting a Postdoctoral Scientist to develop a multimodal Liquid Biopsy for improving the detection and understanding of colorectal cancer.
cruknbc.org
May 13, 2025 at 2:13 PM
We have a position open for a postdoctoral researcher. This is a unique opportunity to develop #liquidbiopsy methods to non-invasively analyse colorectal cancer plasticity and response to treatments. The position is part of the CRC-STARS consortium. @cruknbc.bsky.social cruknbc.org/vacancy-post...
Reposted
Summer placement opportunity for medical students.
Working with @oncocook.bsky.social @aliciamconway.bsky.social and others at the CRUK National Biomarker Centre and The Christie Hospital. Understanding malignancy of unknown origin (MUO). Info below 👇🏻
Working with @oncocook.bsky.social @aliciamconway.bsky.social and others at the CRUK National Biomarker Centre and The Christie Hospital. Understanding malignancy of unknown origin (MUO). Info below 👇🏻
MB-PhD Summer Placement opportunity👩🔬
‘Malignancy of unknown origin: Solving the origin to improve treatments and outcomes’
📆 Deadline: 9 June
🔗https://crukcentre.manchester.ac.uk/opportunities/malignancy-of-unknown-origin-solving-the-origin-to-improve-treatments-and-outcomes/
‘Malignancy of unknown origin: Solving the origin to improve treatments and outcomes’
📆 Deadline: 9 June
🔗https://crukcentre.manchester.ac.uk/opportunities/malignancy-of-unknown-origin-solving-the-origin-to-improve-treatments-and-outcomes/
May 12, 2025 at 7:00 PM
Summer placement opportunity for medical students.
Working with @oncocook.bsky.social @aliciamconway.bsky.social and others at the CRUK National Biomarker Centre and The Christie Hospital. Understanding malignancy of unknown origin (MUO). Info below 👇🏻
Working with @oncocook.bsky.social @aliciamconway.bsky.social and others at the CRUK National Biomarker Centre and The Christie Hospital. Understanding malignancy of unknown origin (MUO). Info below 👇🏻
Reposted
“Trying to improve CUPiD”
AMMF-funded work by Dr Alicia-Marie Conway is adapting the CUPiD platform—originally developed for cancers of unknown primary—to detect confirmed CCA cases. A promising step toward more accurate, non-invasive diagnosis.
@cruk-mi.bsky.social
#AMMF2025
AMMF-funded work by Dr Alicia-Marie Conway is adapting the CUPiD platform—originally developed for cancers of unknown primary—to detect confirmed CCA cases. A promising step toward more accurate, non-invasive diagnosis.
@cruk-mi.bsky.social
#AMMF2025
May 9, 2025 at 10:18 AM
“Trying to improve CUPiD”
AMMF-funded work by Dr Alicia-Marie Conway is adapting the CUPiD platform—originally developed for cancers of unknown primary—to detect confirmed CCA cases. A promising step toward more accurate, non-invasive diagnosis.
@cruk-mi.bsky.social
#AMMF2025
AMMF-funded work by Dr Alicia-Marie Conway is adapting the CUPiD platform—originally developed for cancers of unknown primary—to detect confirmed CCA cases. A promising step toward more accurate, non-invasive diagnosis.
@cruk-mi.bsky.social
#AMMF2025
Reposted
CUPISCO, highlighted potential of early comprehensive genomic profiling in improving treatment outcomes, suggesting that CGP should be incorporated at initial diagnosis to offer personalized tx options, including immunotherapy for patients with high tumor mutation burden
https://buff.ly/4fZbbDy
https://buff.ly/4fZbbDy
November 24, 2024 at 12:31 PM
CUPISCO, highlighted potential of early comprehensive genomic profiling in improving treatment outcomes, suggesting that CGP should be incorporated at initial diagnosis to offer personalized tx options, including immunotherapy for patients with high tumor mutation burden
https://buff.ly/4fZbbDy
https://buff.ly/4fZbbDy